{"id":648157,"date":"2023-04-20T08:46:01","date_gmt":"2023-04-20T08:46:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=648157"},"modified":"2023-04-20T08:46:01","modified_gmt":"2023-04-20T08:46:01","slug":"allerpops-corp-announces-the-beginning-of-the-end-of-the-allergy-era-event","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/allerpops-corp-announces-the-beginning-of-the-end-of-the-allergy-era-event_648157.html","title":{"rendered":"AllerPops Corp. Announces the Beginning of the End of the Allergy Era Event"},"content":{"rendered":"
AllerPops Corp. announces the \u201cBeginning of the End of the Allergy Era\u201d event at the SALA Event Center in Los Alamos, New Mexico. The event will take place between 4 to 6 p.m. on Thursday, May 11th.<\/div>\n

\"\"<\/p>\n

LOS ALAMOS, NM –<\/strong> AllerPops started operations in 2017 and recently completed its research and development-focused phase, which lasted six years. Over the period, the company has expanded its product mix to include prebiotic toothpaste and a variety of new AllerPops flavors. Now, the company is ready to shift its sights to marketing and expanding to national markets.<\/p>\n

Recent efforts have solidified AllerPops’ position as a prime remedy for complete and lasting allergy relief. Most notably, the success of the company’s phase II clinical trial has attested to the safety and efficacy of its product.<\/p>\n

Founder and president Cliff Han views the expansion as a formidable, yet welcome and exciting opportunity. As he puts it, “Moving forward, we will need a capital injection for branding and marketing.<\/p>\n

AllerPops, as a consumer product, has a vast market with over 100 million allergy sufferers in the U.S. On the other hand, it also has a stunning task to get the message to every person in need. Although it may seem costly in the beginning, our thought-leader-based marketing strategy is expected to lessen the cost by tenfold.”<\/p>\n

He ends, “Join and invest in AllerPops. Together, we can end the allergy era and free everyone from this suffering.”<\/p>\n

Seats are limited please register here<\/a>. <\/p>\n

Or scan this QR code.<\/p>\n

\"\"<\/p>\n

About AllerPops<\/strong><\/p>\n

AllerPops Corp. is a Los Alamos, NM-based company dedicated to relieving allergies for long periods, removing the need for daily shots or drugs. The company’s guiding principle is reconnecting customers with nature and the world. https:\/\/allerpops.com\/<\/a><\/p>\n

For media inquiries or to request an interview, please contact:<\/p>\n

Dave Purdy<\/p>\n

david.purdy@otterpr.com<\/a><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Otter Public Relations<\/a>
Contact Person:<\/strong> Dave Purdy
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 7274002578
Address:<\/strong>136 4th St N Ste 201
City:<\/strong> St. Petersburg
State:<\/strong> Florida
Country:<\/strong> United States
Website:<\/strong> www.otterpr.com<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

AllerPops Corp. announces the \u201cBeginning of the End of the Allergy Era\u201d event at the SALA Event Center in Los Alamos, New Mexico. The event will take place between 4 to 6 p.m. on Thursday, May 11th. LOS ALAMOS, NM … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[424,405,437,406,420],"tags":[],"class_list":["post-648157","post","type-post","status-publish","format-standard","hentry","category-Family-Parenting","category-Health-Medicine","category-Lifestyle","category-Pharmaceuticals-Biotech","category-Science"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/648157","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=648157"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/648157\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=648157"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=648157"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=648157"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}